Key result
Anastrozole combined with aspirin and clopidogrel mediated higher levels of breast cancer cell survival and autophagy in vitro compared to each agent individually.
Why the study?
Aromatase inhibitors like anastrozole are first-line therapies for breast cancer in postmenopausal women, but thromboembolic complications are common.
Does the combination of anastrozole, aspirin, and clopidogrel alter cytotoxicity and survival in breast cancer cell lines compared to individual agents?
Does the combination of anastrozole, aspirin, and clopidogrel alter cytotoxicity and survival in breast cancer cell lines compared to individual agents?
The combination of anastrozole with aspirin and clopidogrel promotes breast cancer cell survival and autophagy in vitro, suggesting a potential mechanism for tumor evasion when these drugs are co-administered.
Answers are grounded in this paper and cite their sources.
May promote breast cancer cell survival in vitro; leaves open clinical relevance of anastrozole-antiplatelet interactions.
Globally, breast cancer is among the most frequently diagnosed and common cause of death among women. Aromatase inhibitors, such as anastrozole, are one of the first-line therapies used in the treatment of breast cancer in postmenopausal women; however, thromboembolic complications are common. Thus, this study investigated the combined effects of anastrozole and antiplatelet therapies, aspirin and clopidogrel, on breast cancer cytotoxicity and survival in vitro. Breast cancer cell lines (MCF-7 and T47D) were treated with varying Cmax concentrations of anastrozole and/or antiplatelet therapies for 24 h. A wound-healing scratch assay was used to measure migration and the WST-1 assay for cellular proliferation. An autophagy/cytotoxicity dual staining kit was used to assay cell death and survival. Changes in cell morphology were assessed using scanning electron microscopy. Data were analyzed with Statistica software. Our findings showed that sub-phenotypic differences exist between the luminal-A breast cancer cell lines, with T47D cells being more aggressive than MCF-7 cells. Cellular proliferation and migration responded in a dose-dependent manner for the different treatment groups. Notably, anastrozole combined with aspirin and clopidogrel mediated higher levels of cell survival than each agent individually, with autophagy levels being significantly increased in comparison to that induced with antiplatelet therapy alone.
No takes yet. Share an insight, caveat, or question.
Arnachellen et al. (2023) studied Breast cancer. Anastrozole combined with aspirin and clopidogrel vs. Each agent individually was evaluated on Cell survival and autophagy. Anastrozole combined with aspirin and clopidogrel mediated higher levels of breast cancer cell survival and autophagy in vitro compared to each agent individually.
Synapse has enriched 10 related papers. Consider them for comparative context: